ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,305Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 223

$508K Total Retail Price of All Prescriptions

Rank: 62 out of 223

520 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 520 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 520 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,606 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SIMVASTATIN 390 381 1 1
LISINOPRIL 384 358 2 4
OMEPRAZOLE 352 346 3 3
LEVOTHYROXINE SODIUM 311 266 4 2
PRAVASTATIN SODIUM 307 290 5 15
AMLODIPINE BESYLATE 265 241 6 6
METOPROLOL SUCCINATE 247 224 7 20
ZOLPIDEM TARTRATE 244 224 8 8
TAMSULOSIN HCL 204 204 9 26
DONEPEZIL HCL 180 168 10 36
FUROSEMIDE 179 173 11 9
ATORVASTATIN CALCIUM 177 170 12 17
FINASTERIDE 171 171 13 58
POTASSIUM CHLORIDE 158 158 14 12
METFORMIN HCL 155 146 15 7
HYDROCHLOROTHIAZIDE 144 141 16 13
METOPROLOL TARTRATE 138 137 17 25
WARFARIN SODIUM 135 129 18 11
ALLOPURINOL 129 129 19 28
LOSARTAN POTASSIUM 127 121 20 14
HYDROCODONE-ACETAMINOPHEN 125 113 S3 21 5
LOSARTAN-HYDROCHLOROTHIAZIDE 114 105 22 31
METFORMIN HCL ER 113 113 23 41
DIOVAN 103 101 24 54
TRAMADOL HCL 95 95 25 18
RANITIDINE HCL 94 75 26 65
LANTUS 85 67 27 34
GABAPENTIN 85 76 27 10
FENOFIBRATE 83 76 29 38
FLUTICASONE PROPIONATE 82 77 30 27
AZITHROMYCIN 82 73 30 44
PREDNISONE 77 59 32 43
SYNTHROID 73 56 33 35
FLUOXETINE HCL 72 72 34 24
CITALOPRAM HBR 72 71 34 16
PAROXETINE HCL 70 70 36 52
GLIPIZIDE 64 59 37 112
ZETIA 64 54 37 68
CYMBALTA 63 47 39 40
ALENDRONATE SODIUM 58 58 40 19
EVISTA 58 58 40 92
SERTRALINE HCL 58 58 40 21
PANTOPRAZOLE SODIUM 55 51 43 45
CARVEDILOL 51 40 44 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 48 44 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.